178 related articles for article (PubMed ID: 6625590)
1. Regulatory control and standardization of allergenic extracts. Standardized extracts in therapy.
Turkeltaub PC
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):83-6. PubMed ID: 6625590
[No Abstract] [Full Text] [Related]
2. Grass pollen hyposensitization versus placebo therapy.
Weyer A; Heritier CL; David B
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):101-7. PubMed ID: 6354089
[No Abstract] [Full Text] [Related]
3. Regulatory control and standardization of allergenic extracts. Clinical methods of evaluation of extracts.
Norman PS
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):65-9. PubMed ID: 6625586
[No Abstract] [Full Text] [Related]
4. Differential rates of allergen release: an important consideration in the preparation of allergenic extracts.
Marsh DG
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1987; (80):47-57. PubMed ID: 3688873
[No Abstract] [Full Text] [Related]
5. [Specific brief immunotherapy receives MMW Drug Prize 2004. Four pricks expel pollen allergy].
Füessl HS
MMW Fortschr Med; 2004 Sep; 146(37):13. PubMed ID: 15887695
[No Abstract] [Full Text] [Related]
6. A double-blind, placebo-controlled study of preventive immunotherapy with E.P.D., in the treatment of seasonal allergic disease.
Di Stanislao C; Di Berardino L; Bianchi I; Bologna G
Allerg Immunol (Paris); 1997 Feb; 29(2):39-42. PubMed ID: 9084819
[TBL] [Abstract][Full Text] [Related]
7. [A new desensitization agent in the treatment of ragweed-induced seasonal allergic rhinitis (hay fever) in children: MRTA (modified ragweed tyrosine adsorbate)].
Weisnagel J
Union Med Can; 1979 Jun; 108(6):685-90. PubMed ID: 116408
[No Abstract] [Full Text] [Related]
8. Design of protocols to evaluate the safety and efficacy of allergenic extracts.
Van Metre TE
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1987; (80):229-37. PubMed ID: 3688865
[No Abstract] [Full Text] [Related]
9. Design of protocols to evaluate the safety and efficacy of allergenic extracts.
Bousquet J; Guerin B; Michel FB
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1987; (80):213-28. PubMed ID: 3318696
[No Abstract] [Full Text] [Related]
10. Regulatory control and standardization of allergenic extracts. The clinical trial protocol.
Aas K
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):55-63. PubMed ID: 6354091
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
12. Polymerized allergens.
Patterson R; Suszko IM
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):241-6. PubMed ID: 6354090
[No Abstract] [Full Text] [Related]
13. Clinical evaluation of desensitization therapy in hay fever.
Dieges PH
Acta Otorhinolaryngol Belg; 1979; 33(4):522-7. PubMed ID: 395812
[No Abstract] [Full Text] [Related]
14. [Etiology, clinical aspects and therapy of allergic rhinitis].
Muminov AI; Abdurakhimov KG
Vestn Otorinolaringol; 1978; (3):48-50. PubMed ID: 148765
[No Abstract] [Full Text] [Related]
15. Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. I. Results of tests in vivo.
Berg T; Nordvall SL; Lanner A
Int Arch Allergy Appl Immunol; 1980; 63(3):266-74. PubMed ID: 7419290
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination with allergens in children].
Demoly P; Dhivert-Donnadieu H; Bousquet J
Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
[TBL] [Abstract][Full Text] [Related]
17. [Desensitization therapy with aqueous pollen extracts in pollinosis].
Loechel I; Kern A
Dermatol Monatsschr; 1970; 156(6):602-7. PubMed ID: 5515612
[No Abstract] [Full Text] [Related]
18. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
[TBL] [Abstract][Full Text] [Related]
20. The effect of immunotherapy on allergen induced late responses.
Durham SR; Hamid QA
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):33-9. PubMed ID: 9383889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
